Abstract
OBJECTIVE To evaluate whether incorporating baseline sleep measures from a wrist-worn activity monitor in machine learning (ML) models improved the prediction of 12-week engagement with home-based pulmonary rehabilitation (HBPR) in patients with chronic obstructive pulmonary disease (COPD).
PATIENTS AND METHODS Among participants with a COPD exacerbation (n=124), sleep measures were collected for 1 week before HBPR and processed (1) using a validated Tudor-Locke algorithm and (2) applying partial least squares-discriminant analysis (PLS-DA) to generate the Composite Sleep Health Score. Engagement was defined as completion of one or more recommended activities per week for the 12-week duration. Nested model comparisons for logistic regression, SVM, decision tree, and naïve bayes ML models were performed to determine if including sleep measures improved engagement prediction.
RESULTS In models adjusted for age, sex, Charlson Comorbidity Index, current smoker status, modified Medical Research Council score, and forced expiratory volume in 1 second, the inclusion of the Composite Sleep Health Score significantly improved the prediction of 12-week engagement only in SVM models (AUC 0.716; p=0.010). Specificity (18.2%) and accuracy (67.7%) also improved by 20.4% and 2.5%, respectively. Including the Score in the logistic regression model yielded the highest predictive performance (AUC = 0.721).
CONCLUSION These proof-of-concept findings support additional investigation into the use of wearable-derived sleep measures in parametric ML models to improve screening for HBPR eligibility, identifying patients who will clinically benefit from fully remote PR. Future researchers should carefully select predictors when elucidating the link between wearable sleep measures and HBPR outcomes in COPD patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this study was provided by NIH R56 HL173214, NIH R01 HL140486, and the Robert D. and Patricia E. Kern Center for the Science of Health Delivery. Funding for the Prostate Cancer and AI Falls Projects is from the Robert D. and Patricia E. Kern Center for the Science of Health Delivery.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review board at Mayo Clinic approved the study (17-009449). This study was conducted in compliance with the Declaration of Helsinki regarding ethics principles for medical research involving human subjects. Patients were informed of their right to object to the use of their data for the present study and gave their informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Financial support: Funding for this study was provided by NIH R56 HL173214, NIH R01 HL140486, and the Robert D. and Patricia E. Kern Center for the Science of Health Delivery. Funding for the Prostate Cancer and AI Falls Projects is from the Robert D. and Patricia E. Kern Center for the Science of Health Delivery.
Conflict of interest disclosure: The authors report no conflicts of interest.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
ABBREVIATIONS
- ML
- machine learning
- COPD
- chronic obstructive pulmonary disease
- PR
- pulmonary rehabilitation
- HBPR
- home-based pulmonary rehabilitation
- PLS-DA
- partial least squares-discriminant analysis
- SVM
- support vector machine
- CCI
- Charlson comorbidity index
- mMRC
- modified medical research council
- FEV1
- forced expiratory volume in 1 second
- AUC
- area under ROC curve
- ROC
- receiver operating characteristic
